External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ERA 2022
Roche and Genentech at

ERA 2022

September 01 - September 03
Paris, France / Virtual (Hybrid)
era-online.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:00 AM
Duration 15mins Paris
A study to ascertain the optimum starting dose of subcutaneous (SC) C.E.R.A. for maintenance treatment of anaemia in paediatric patients with chronic kidney disease (CKD) on dialysis or not yet on dialysis
Warady BA, Reigner SM, Tirodkar C, Drozdz D
Nephrology | Chronic Kidney Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 4mins Paris
CERA (continuous erythropoietin receptor activator – methoxy polyethylene glycol epoetin beta) in paediatric dialysis patients with anaemia of chronic kidney disease: Real-world evidence from the IPDN and IPHN registries
Schaefer F, Benner L, Sander A, Rutten-Jacobs L, Kim YH, Vondrak K, Coccia PA, Cano F, Meyer Reigner S, Studer M
Nephrology | Chronic Kidney Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.